Plant Summary
TCMBank_ID: | TCMBANKHE003880 |
ID: | TCMBANKHE003880 |
植物拉丁名: |
|
功能与主治: | To dissipate cold, relieve pain, expel roundworm./Stomach cold, stomachache due to roundworm, toothache, damp sore. |
药用植物名: | 竹叶椒 |
药用部位: | fruit |
TCM_ID_id: | 5378 |
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN000388 | vinyl laurate | C14H26O2 | 226.35 g/mol | CCCCCCCCCCCC(=O)OC=C | |
TCMBANKIN001057 | newolidol | ||||
TCMBANKIN016229 | Norchelerythrine | norchelerythrine; 6900-99-8; C12226; ZINC00900935; (1,3)Benzodioxolo(5,6-c)phenanthridine, 1,2-dimethoxy- | C20H15NO4 | 333.34 | COC1=C(C2=CN=C3C(=C2C=C1)C=CC4=CC5=C(C=C43)OCO5)OC |
TCMBANKIN016869 | CiS, CiS, CiS-7,10,13-hexadecatrienal | cis,cis,cis-7,10,13-hexadecatrienal | C16H26O | 234.38 g/mol | CCC=CCC=CCC=CCCCCCC=O |
TCMBANKIN017569 | benzenepropanoic acid, β-[(3-methoxy-1, 3-dioxopropyl)amino] methyl ester | ||||
TCMBANKIN018780 | zanthpodocarpin A | C41H44O14 | COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4C(C5(C(=CC4=O)OCO5)OC6=C(C=C(C=C6)C7C8COC(C8CO7)C9=CC(=C(C=C9)O)OC)OC)O)OC | ||
TCMBANKIN019597 | de-4′, 4″-O-dimethylepimagnolin | ||||
TCMBANKIN020069 | falaconitine | C34H47NO10 | 629.7 g/mol | CCN1CC2(C(CC(C34C2C(C(C31)C5=CC(C6(CC4C5C6OC(=O)C7=CC(=C(C=C7)OC)OC)O)OC)OC)OC)O)COC | |
TCMBANKIN020836 | xanthopterin | 2-amino 4,6 pteridinedione | C6H5N5O2 | 179.14 g/mol | C1=NC2=C(C(=O)NC(=N2)N)NC1=O |
TCMBANKIN020979 | dictysine | C21H33NO3 | 347.5 g/mol | CC12CCCC34C1CC(C3N(C2)C)C56C4CC(CC5)C(C6O)(CO)O | |
TCMBANKIN021949 | 3-O-(E)-feruloyl quinic acid methyl ester | ||||
TCMBANKIN024016 | Arnottianamide | Formamide, N-(6-(2-hydroxy-3,4-dimethoxyphenyl)naphtho(2,3-d)-1,3-dioxol-5-yl)-N-methyl-; arnottianamide; N-[7-(2-hydroxy-3,4-dimethoxy-phenyl)benzo[f][1,3]benzodioxol-8-yl]-N-methyl-formamide; N-[7-(2-hydroxy-3,4-dimethoxy-phenyl)benzo[f][1,3]benzodioxol-8-yl]-N-methyl-methanamide; N-[7-(2-hydroxy-3,4-dimethoxyphenyl)-8-benzo[f][1,3]benzodioxolyl]-N-methylformamide; ZINC04716569; 60394-88-9; N-[7-(2-hydroxy-3,4-dimethoxyphenyl)benzo[f][1,3]benzodioxol-8-yl]-N-methylformamide | C21H19NO6 | 381.38 | CN(C=O)C1=C(C=CC2=CC3=C(C=C21)OCO3)C4=C(C(=C(C=C4)OC)OC)O |
TCMBANKIN024761 | 4,5,6,6a-tetrahydro-2(1H)-pentalenone | C8H10O | 122.16 g/mol | C1CC2CC(=O)C=C2C1 | |
TCMBANKIN028214 | Decarine | decarine; AIDS-342572; AIDS342572; [1,3]Benzodioxolo[5,6-c]phenanthridin-2-ol, 1-methoxy-; 54354-62-0 | C19H13NO4 | 319.31 | COC1=C(C=CC2=C3C=CC4=CC5=C(C=C4C3=NC=C21)OCO5)O |
TCMBANKIN028484 | platydesmine | C15H17NO3 | 259.3 g/mol | CC(C)(C1CC2=C(C3=CC=CC=C3N=C2O1)OC)O | |
TCMBANKIN031501 | biplanispin B | ||||
TCMBANKIN035382 | vinyl decanoate | C12H22O2 | 198.3 g/mol | CCCCCCCCCC(=O)OC=C | |
TCMBANKIN038023 | xanthoplanine | Alkaloid FR-1; (+)-Xanthoplanine; 5-hydroxy-4,15,16-trimethoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium | C23H30NO4 | 385 | c1(OC([H])([H])[H])c([H])c2c([C@]([H])(C([H])([H])c(c([H])c(O[H])c(OC([H])([H])C([H])([H])[H])c3[H])c34)N(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])c4c1OC([H])([H])C([H])([H])[H] |
TCMBANKIN043323 | Plantaginin | 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; plantaginin; 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone | C21H20O11 | 448.38 | C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O |
TCMBANKIN043518 | 6-Acetoxy-9-hydroxy-13(14)-labden-16,15-olide | 379 | |||
TCMBANKIN044947 | 4-Nerolidylcatechol | 314.5 g/mol | |||
TCMBANKIN058044 | (Z)-9,17-octadecadienal | (9Z)-octadeca-9,17-dienal; (9Z)-9,17-Octadecadienal; 9,17-Octadecadienal, (Z)-; 56554-35-9; 9,17-OCTADECADIENAL (Z) | C18H32O | 264.4 g/mol | C=CCCCCCCC=CCCCCCCCC=O |
TCMBANKIN058839 | Farnesol acetate | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate; acetic acid 3,7,11-trimethyldodeca-2,6,10-trienyl ester; InChI=1/C17H28O2/c1-14(2)8-6-9-15(3)10-7-11-16(4)12-13-19-17(5)18/h8,10,12H,6-7,9,11,13H2,1-5H3/b15-10+,16-12; 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (2E,6E)-; All-trans-Farnesyl acetate; farnesol acetate; 4128-17-0; 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate; 340480_ALDRICH; 29548-30-9; NSC132958; AI3-33837; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate; 3,7,11-Trimethyldodeca-2,6,10-trienyl acetate; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ethanoate; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (E,E)-; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate; acetic acid [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ester; 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate; 3,7,11-trimethyldodeca-2,6,10-trienyl ethanoate; trans,trans-Farnesyl acetate; 45895_FLUKA; EINECS 249-689-1; ZINC01719908; 3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate; NSC 132958;trans,trans-farnesyl acetate;Farnesyl acetate;Tox21_302688; AKOS025295075; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate; ACM29548309; D5ZJ1FOC2I; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate; Farnesyl acetate, 95%, mixture of cis and trans; MolPort-002-135-206; trans-2-trans-6-Farnesyl acetate; (2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate; 162327-52-8; Farnesol acetate; ST50826011; UNII-D5ZJ1FOC2I; E,E-Farnesyl Acetate; Farnesyl acetate, mixture of isomers; S14-1289; (E,E)-farnesyl acetate; InChI=1/C17H28O2/c1-14(2)8-6-9-15(3)10-7-11-16(4)12-13-19-17(5)18/h8,10,12H,6-7,9,11,13H2,1-5H3/b15-10+,16-12; 2-trans-6-trans-Farnesyl acetate; MFCD00036516; acetic acid [(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] ester; TR-012831; 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (2E,6E)-; Farnesyl acetate, technical, mixture of isomers; All-trans-Farnesyl acetate; LMFA07010230; [(E,E)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-yl]ester of acetic acid; ZGIGZINMAOQWLX-NCZFFCEISA-N; (E)-Farnesyl acetate; DTXSID5047110; trans, trans-Farnesyl acetate; DSSTox_GSID_47110; farneoylacetate; 4128-17-0; 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate; trans,trans-Farnesyl acetate, 95%; Farnesyl acetate, (E,E)-; A819958; 29548-30-9; NSC132958; DSSTox_CID_27110; Acetic acid (6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl ester; (cis,trans)-Farnesyl acetate; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate; [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ethanoate; AC1LCWI8; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (E,E)-; UNII-2ARF3ZNJ1R component ZGIGZINMAOQWLX-NCZFFCEISA-N; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate; acetic acid [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ester; AC1Q65TN; J-500791; (2E,6Z)-1-Acetoxy-3,7,11-trimethyl-2,6,10-dodecatriene; trans,trans-Farnesyl acetate; farnesyl acetate; farnesyl acetate, No Antioxidant; [(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] ethanoate; 1192109-55-9; 3,11-Trimethyl-2,6,10-dodecatrienyl acetate; (2Z,6Z)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-ol acetate; Farnesyl acetate, (2E,6E)-; (2E,6E)-Farnesyl acetate; trans2,trans6-Farnesyl acetate; DSSTox_RID_82120; 2,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate; NCGC00256905-01; CHEMBL3184169; ZINC1719908; CAS-4128-17-0; [(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate; NSC-132958 | C17H28O2 | 264.4 g/mol | CC(=CCCC(=CCCC(=CCOC(=O)C)C)C)C |
TCMBANKIN059987 | alpha-bisabolol | C15H26O | 222.37 | CC1=CCC(CC1)C(C)(CCC=C(C)C)O | |
TCMBANKIN060884 | linoleyl alcohol | C18H34O | 266.46 g/mol | CCCCCC=CCC=CCCCCCCCCO | |
TCMBANKIN060978 | Mnk | C11H22O | 170.29 | CCCCCCCCCC(=O)C | |
TCMBANKIN061698 | Dictamine | Spectrum3_000101; SPECTRUM100541; C10660; Furo(2,3-b)quinoline, 4-methoxy-; dictamnine; Furo[2,3-b]quinoline, 4-methoxy-; KBio2_006213; NCGC00095429-01; SDCCGMLS-0066336.P001; Dictamnine; CCRIS 1583; Spectrum2_000349; Oprea1_294767; KBio3_000802; 484-29-7; Spectrum4_001383; dictamine ; Oprea1_134081; DivK1c_006140; SPBio_000417; SpecPlus_000044; 4-methoxyfuro[2,3-b]quinoline; Spectrum_000597; KBio2_003645; KBioSS_001077; BSPBio_001682; KBio2_001077; dictamine; KBioGR_001706; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932;Spectrum3_000101; SPECTRUM100541; AC1L2901; LS-70926; C10660; Furo(2,3-b)quinoline, 4-methoxy-; DTXSID0041012; Furo[2,3-b]quinoline, 4-methoxy-; MCULE-6817939774; MolPort-003-665-620; C12H9NO2; AM-331/20711025; KBio2_006213; CTK4J0807; NCGC00095429-01; AKOS006274709; SDCCGMLS-0066336.P001; Dictamnine; Furo[2,3-b]quinoline,4-methoxy-; NCGC00095429-02; CCRIS 1583; FT-0686595; Spectrum2_000349; Oprea1_294767; V0176; KBio3_000802; 4-Methoxyfuro[2,3-b]quinoline #; 484-29-7; Spectrum4_001383; BRD-K29178788-001-01-2; 4-Methoxyfuro[2,3-b]quinoline; CCG-38624; Oprea1_134081; DivK1c_006140; SR-05000002442; Q-100537; WIONIXOBNMDJFJ-UHFFFAOYSA-N; SPBio_000417; SR-05000002442-1; SpecPlus_000044; CS-3267; Spectrum_000597; N2224; 484D297; CHEBI:4512; KBio2_003645; BSPBio_001682; KBioSS_001077; HQZ3798D0A; Diktaminin; SCHEMBL1760700; Dictamine; CHEMBL22533; VU0243862-3; HY-N0849; KBio2_001077; KBioGR_001706; UNII-HQZ3798D0A; HMS3561L11; AN-45222; 4-Methoxy-furo[2,3-b]quinoline; ZINC265517; AC1Q4FDA; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932 | C12H9NO2 | 199.21 | COC1=C2C=COC2=NC3=CC=CC=C31 |
TCMBANKIN061871 | gamma-fagarine | gamma-fagarine;Oprea1_872079; CCRIS 1584; Oprea1_404574; BRN 0212820; 8-Methoxydictamine; MLS001048993; MLS000532362; fagarine; Furo[2,3-b]quinoline, 4,8-dimethoxy-; C10676; .gamma.-Fagarine; 4,8-dimethoxyfuro[2,3-b]quinoline; ZINC00199415; SMR000137321; ST077119; gamma-Fagarine; Furo(2,3-b)quinoline, 4,8-dimethoxy-; AIDS342574; 4-27-00-02211 (Beilstein Handbook Reference); 524-15-2; CBDivE_012859; AIDS-342574;γ-fagarine;Fagarine | C13H11NO3 | 229.23 g/mol | COC1=CC=CC2=C1N=C3C(=C2OC)C=CO3 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
---|